VANCOUVER, BC, June 21,
2022 /CNW/ - Numinus Wellness Inc. ("Numinus")
(TSX: NUMI) (OTC: NUMIF), a mental health care company advancing
innovative treatments and safe, evidence-based psychedelic-assisted
therapies, today announced that it will participate in the H.C.
Wainwright 1st Annual Mental Health Conference to
be held at the Lotte New York Palace Hotel in New York City on Monday, June 27, 2022.
Payton Nyquvest, Founder and CEO
of Numinus, will present live virtually at 11:00 a.m. ET. To attend, please register
here.
For more information about the conference, or to schedule a
one-on-one meeting with Numinus' management, please contact your
appropriate H.C. Wainwright representative directly, or send an
email to KCSA Strategic Communications NuminusIR@kcsa.com.
About Numinus
Numinus Wellness (TSX: NUMI) helps people to heal and be well
through the development and delivery of innovative mental health
care and access to safe, evidence-based psychedelic-assisted
therapies. The Numinus model – including psychedelic production,
research and clinic care – is at the forefront of a transformation
aimed at healing rather than managing symptoms for depression,
anxiety, trauma, pain and substance use. At Numinus, we are leading
the integration of psychedelic-assisted therapies into mainstream
clinical practice and building the foundation for a healthier
society.
Learn more at www.numinus.com and follow us on LinkedIn,
Facebook, Twitter, and Instagram.
Disclaimer:
Neither Numinus Wellness Inc., nor any of its subsidiaries is
a professional corporation licensed to practice health services. In
jurisdictions where health services may only be provided by a
corporation if that corporation holds a valid permit to do so,
Numinus and its subsidiaries operate in a management services
function to affiliated professional corporations, who provide
health services to patients. Numinus and its subsidiaries do
provide health services directly to patients in those jurisdictions
where authorized to do so.
Forward-looking
statements
Statements and other information contained in this press
release about anticipated future events constitute forward-looking
statements. Forward-looking statements are often, but not always,
identified by the use of words such as "seek", "anticipate",
"believe", "plan", "estimate", "expect" and "intend" and statements
that an event "may", "will", "should", "could" or "might" occur or
other similar expressions. Forward-looking statements are subject
to risks and uncertainties and other factors that could cause
actual results to differ materially from those contained in the
forward-looking statements. Forward-looking statements are based on
estimates and opinions of management at the date the statements are
made. The Company does not undertake any obligation to update
forward-looking statements even if circumstances or management's
estimates or opinions should change except as required by
applicable laws. Investors should not place undue reliance on
forward-looking statements.
View original
content:https://www.prnewswire.com/news-releases/numinus-to-participate-in-the-hc-wainwright-1st-annual-mental-health-conference-on-june-27-2022-301572442.html
SOURCE Numinus Wellness Inc.